The line between disciplining medical misconduct and policing medical speech is not a nuance for lawyers; it is the hinge on which patient safety, public trust, and physicians’ First Amendment rights all turn.
At a Glance
- State medical boards wield broad sanctioning power, but that authority is bounded by law and must tie to protecting patients, not punishing viewpoints.
- Boards have increasingly asserted the ability to act against “misinformation,” while courts and scholars stress discipline must be rationally related to medical practice and not unmoored speech policing.
- Despite heightened rhetoric, formal discipline for COVID-19 misinformation has been rare; overall disciplinary rates vary widely by state for many reasons unrelated to speech.
- The durable standard is conduct-based regulation: discipline stands strongest when tied to patient harm, deceptive practice, or incompetence, not to a doctor’s public dissent alone.
What Boards Can Do—and What They Can’t
Every state empowers its medical board to sanction licensees, often with a formidable toolkit: revocation, suspension, fines, probation, mandated education, and more. Massachusetts’ rule set is typical of this breadth, authorizing penalties up to and including license cancellation and five-figure fines per violation. Connecticut’s statute, like many, sweeps in restriction, suspension, or revocation for enumerated grounds, from impairment to unprofessional conduct. Hawaii’s board can stack sanctions—probation, educational requirements, and fines—on top of other actions, reflecting the nationwide pattern: broad remedial discretion justified as a public protection mandate. The Federation of State Medical Boards (FSMB) describes this architecture in its guidance: boards exist to shield the public from incompetence, impairment, and fraud; they are not designed as roving arbiters of ideas.
That distinction—public protection versus viewpoint policing—anchors constitutional and administrative limits. Disciplinary regimes must rest on standards that are neither vague nor untethered from medical practice. In the leading academic treatment, professional discipline is constrained by substantive due process: grounds for licensure and sanction must be rationally related to the practice of medicine, and penalties must be proportionate to the misconduct proved. In plain terms, boards have power, but they must use it to remedy genuine professional failings—unsafe care, deceptive claims in a clinical or commercial context, impaired practice—not to punish unpopular speech per se.
Speech, Conduct, and the COVID-19 Stress Test
The pandemic pulled this tension taut. Some boards and national certifying bodies warned that spreading COVID-19 “misinformation” could threaten a license or certification, framing it as unprofessional conduct that erodes public trust and endangers patients. FSMB amplified that posture and later tracked state-level proposals to circumscribe board authority in this space, underscoring that the boundaries of speech-related discipline had become a live political fight as well as a regulatory one. Public health advocates argued the harms of misinformation—vaccine falsehoods, unsupported therapeutics—were not abstract; they risked real morbidity and mortality and should trigger professional accountability.
Yet when accusations met process, the disciplinary footprint was surprisingly small. Analyses of board actions during the period show that formal discipline for spreading COVID-19 misinformation was rare relative to the rhetoric—not zero, but a tiny fraction of total actions. One review found less than 1% of disciplinary cases in the five most populous states involved misinformation claims; most involved classic grounds like impairment, criminal acts, prescribing, or boundary violations. That base rate matters. Nationally, about 3.75 disciplinary actions per 1,000 physicians occur annually (1.15 are “serious”), and rates vary almost fourfold by state; speech-related charges are a sliver of that activity.
Where Boards’ Case Theory Is Strongest
Boards succeed, and withstand review, when they proceed on conduct that directly implicates patient care or professional integrity. Two recurring anchors are: (1) patient-specific harm or clear risk—such as issuing blanket mask or vaccine exemptions without individualized evaluation—or (2) commercial deception—such as marketing unproven cures as effective treatments in a manner likely to mislead patients seeking care. These theories connect the physician’s actions to the practice of medicine, not simply to opinion-sharing, and they fit comfortably within established “unprofessional conduct” categories recognized across jurisdictions and summarized in ethics and regulatory literature. Where regulators stayed in that lane—proving falsity, materiality, and nexus to practice—sanctions were more sustainable than when they chased generalized online speech detached from any clinical transaction.
Courts and commentators have thus coalesced around a workable partition. A physician’s public commentary, even if caustic or dissenting, sits closer to protected opinion unless it crosses into professional conduct: patient-specific directives, clinical representations offered in a therapeutic relationship, or commercial claims likely to deceive. Scholarship distills the constitutional principle: discipline grounded in vague notions of professional “character” or viewpoint is vulnerable; discipline grounded in demonstrable clinical risk or deception is not.
Where Boards’ Case Theory Falters
Attempts to sanction physicians purely for contrarian public statements—tweets, op-eds, or interviews—have been difficult to square with due process constraints and First Amendment norms that apply with special force outside the clinic. Even in high-profile pushes, sustained, final discipline for public-facing COVID dissent alone has been uncommon, and investigative forays often closed without action or with modest, educational dispositions. The rarity here is not simply political hesitancy; it reflects the evidentiary burden of proving that speech was both false in a legally cognizable way and tied to professional practice such that patient protection justifies state coercion.
That balance has informed recent litigation and emergency-relief skirmishes. While some plaintiffs sought to preempt board investigations into alleged misinformation, courts have been reluctant to grant blanket shields, distinguishing investigative authority from punitive overreach. A notable example: a bid to block Washington State’s regulator from probing misinformation allegations failed at the U.S. Supreme Court’s emergency docket stage, leaving the commission free to investigate, though not prejudging merits or ultimate discipline. The signal is consistent: boards may look, but punishment must be justified on classic, practice-linked grounds.
The Durable Standard Going Forward
Strip away the pandemic heat and the long-run rule is clearer than the headlines suggested. State medical boards can and should act decisively against physicians whose conduct—impaired practice, predatory behavior, dangerous prescribing, fraudulent marketing—threatens patients. Their statutory tools are wide and their public-protection mandate is real. But when boards attempt to treat generalized public dissent as sanctionable by itself, they run into the hard stop that scholarly doctrine and case experience impose: professional discipline must be rationally related to the practice of medicine and supported by clear, non-vague standards.
Practically, that means the most defensible pathway remains conduct-centric. If a doctor issues baseless medical exemptions without examination, recommends contraindicated regimens to identifiable patients, or markets quack therapies with deceptive claims, discipline rests on solid ground. If the same doctor posts an intemperate thread criticizing mandates or expressing skepticism about a public-health study, the case for discipline evaporates unless the speech is welded to professional acts that jeopardize patients. Ethics guidance and regulatory analyses converge on this line, even as perspectives diverge on how aggressively to police the margin.
A 2023 review of board records found at least 20 U.S. doctors penalized for COVID-related “misinformation” complaints (Jan 2020–June 2023); five lost licenses (one revoked, four surrendered). Discipline was often linked to patient-care issues, not speech alone. Major boards…
— Luna Tune (@byebyeWEF) August 2, 2026
Implications for Physicians, Patients, and Boards
For physicians, the rule of thumb is straightforward. Your license lives where your practice lives. Maintain documentation, avoid blanket exemptions, ground recommendations in defensible evidence, and separate public commentary from clinical marketing. For patients and the public, the takeaway is equally practical. Boards excel at addressing concrete threats—impaired, dishonest, or incompetent practice. They are blunt instruments for adjudicating scientific debates in real time. And for boards, the lasting lesson of the COVID era is methodological humility: investigate when complaints credibly implicate patient risk or deception; charge only where the evidence ties back to practice; and resist the temptation to convert professional discipline into a proxy battle over contested ideas.
Sources:
lifesitenews.com, mass.gov, isomer-user-content.by.gov.sg, code-medical-ethics.ama-assn.org, infectedbloodinquiry.org.uk, elft.nhs.uk, journalofethics.ama-assn.org, pmc.ncbi.nlm.nih.gov, pbieducation.com, jamanetwork.com, bmj.com, bmj-chicken.bmj.com, phr.org, clearhq.org, finance.yahoo.com, scholarlycommons.law.wlu.edu
